30/11/2020
Call for more effective EU regulation of clinical trials with Advanced Therapy
Medicinal Products consisting of or containing Genetically Modified Organisms
25/11/2020
An EU IP Action Plan for strong industrial ecosystems
25/11/2020
EuropaBio looks forward to working closely with the European institutions to ensure the Pharmaceutical Strategy delivers for European patients and establishes a framework that enables a successful life sciences sector for the medium to long-term.
10/11/2020
Bioplastics are plastics which are bio-based, biodegradable or both. Bio-based plastics are produced from biomass, which helps to decrease our dependence on fossil carbon resources (the feedstock for conventional plastics). They can offer significant CO2 emissions savings compared to conventional plastics.
02/11/2020
EuropaBio announces Dr. Claire Skentelbery as new Director General of the Association.
20/10/2020
EuropaBio Position Paper on the use of Real-World Data (RWD) and Real-World Evidence (RWE) for regulatory decision-making.
19/10/2020
EuropaBio and its members would like to engage the European Commission and all relevant stakeholders in a discussion on the future use of the HE in the context of the new EU Pharmaceutical Strategy and its accompanying actions.
07/10/2020
Brussels, 7 October 2020: Today, genome editing pioneers Emmanuelle Charpentier and Jennifer A. Doudna have been awarded the Nobel Prize in Chemistry 2020
02/10/2020
As Europe looks to the implementation of the EU Green Deal and a sustainable post-COVID future, this year’s conference will highlight how industrial biotechnology and bio-based innovation can play a key role in the transition to a more sustainable and circular economy.
30/09/2020
EuropaBio Patient engagement with the European Medicines Agency
24/09/2020
Genome editing is an advance in biological tools with the potential for a wide range of applications.
03/09/2020
Novartis’s Andrew Topen appointed as new Chairman of EuropaBio.
24/08/2020
This is a non-exhaustive list of over 200 genome-editing or viral vector related products and research projects, drawn from various resources and covering healthcare, industrial and agricultural biotech
13/08/2020
Read our Statement in response to the publication of the European Commission’s evaluation of the Orphan and Paediatric Regulations.
03/08/2020
Health industry sectors, representing pharmaceutical and medical technology companies welcome the publication of the Partnership Proposal as a significant milestone towards a European Partnership for Health Innovation.
30/07/2020
Joint response of EuropaBio and BIO on the EU Data Strategy Consultation.
30/07/2020
EuropaBio response to the public consultation on the Roadmap for an EU Pharmaceutical Strategy.
30/07/2020
Read our response on the eHSG Work Programme 2020-2022.
15/07/2020
Read our position paper on the Farm to Fork strategy.
30/06/2020
EuropaBio welcomes the European Commission’s commitment to develop a European plan to fight cancer and is supportive of its overarching approach in tackling all key stages of the disease: prevention, early diagnosis, treatment, and quality of life. Above all, we strongly advocate the employment of supportive measures for health innovation to ensure that novel cancer treatments move from the laboratory to the hospital bedside as swiftly as possible.